Lawyers and Settlements
What are you looking for?
Email to a friendEmail
Home Page >> Lawsuits Filed >> Lawsuit: Bladder Cancer Victims File Actos Lawsuit

Bladder Cancer Victims File Actos Lawsuit

Seattle, WA: A nationwide lawsuit has been filed by people who have taken the diabetes medication Actos (pioglitazone) alleging it is associated witht the development of bladder cancer. The lawsuit is not a class action, rather each qualifying individual will seek damages consistent with the merits of his or her individual case. To qualify to join the Actos lawsuit, one must meet basic criteria, including that one has taken Actos and developed bladder cancer.

Actos is one of the most popular diabetes drugs in the world. Recently, however, studies have shown that Actos use is linked to serious side effects, particularly bladder cancer. These studies show that the longer one takes Actos, the greater the risk of developing bladder cancer. As a result of this mounting scientific evidence, the FDA has issued warnings regarding Actos and bladder cancer. In France, the French Agency for Safety of Health Products recalled Actos from the market on June 9, 2011. Regulators in Germany recommended that physicians not prescribe it.

If you or a loved one took Actos and developed bladder cancer, you may have a case against the manufacturer of Actos. Time limits exist that limit the amount of time you have to join the lawsuit, so if you think you may have a claim.

Actos Bladder Cancer Lawsuit Legal Help

If you or a loved one has suffered damages in this case, please click the link below and your complaint will be sent to a lawyer who may evaluate your claim at no cost or obligation.

Last updated on Oct-4-11

YOUR STORIES

Publish your experience here for our readers to learn from.



Related Lawsuits

Legal Services:

Facebook





Better Business Bureau

CAALA

Best of the Web Approved

Public Justice
 
FAQ | TOS | Privacy | Disclaimer | About Us | Contact Us | Press | Advertise | Member Login | Site Map

This work is licensed under a Creative Commons Attribution-NoDerivs 3.0 Unported License © 2001-2012 Online Legal Media. All rights reserved.